Hurley Capital
SANA icon

Hurley Capital’s Sana Biotechnology SANA Stock Holding History

Hurley Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.83K Hold
2,000
– – ﹤0.01% 398
2026
Q2 		$6.98K Hold
2,000
– – ﹤0.01% 373
2026
Q1 		$5.76K Hold
2,000
– – ﹤0.01% 402
2025
Q4 		$8.14K Hold
2,000
– – ﹤0.01% 355
2025
Q3 		$7.1K Buy
+2,000
New +$7.23K ﹤0.01% 403

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Hurley Capital's SANA Position: Q3 2026 in Review

Hurley Capital held its Sana Biotechnology (SANA) position steady in Q3 2026 at 2,000 shares worth $5.83K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Hurley Capital first reported a position in SANA in Q3 2025 and has held it in 5 quarters since. The position peaked at $8.14K in Q4 2025. 142 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Hurley Capital held 2,000 shares of Sana Biotechnology worth $5.83K as of Q3 2026.
  • Hurley Capital left its Sana Biotechnology share count unchanged in Q3 2026.
  • Sana Biotechnology made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #398 holding.
  • Hurley Capital first reported a position in Sana Biotechnology in Q3 2025 and has held it in 5 quarters since.
  • Hurley Capital's Sana Biotechnology position peaked at $8.14K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.